Publications by authors named "Victoria E Wang"

9Publications

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden.

J Immunother Cancer 2017 09 19;5(1):75. Epub 2017 Sep 19.

Department of Surgery, University of California, San Francisco, USA.

View Article and Find Full Text PDF
September 2017

A Case of Metastatic Atypical Neuroendocrine Tumor with Translocation and Diffuse Brain Metastases.

Oncologist 2017 07 15;22(7):768-773. Epub 2017 May 15.

Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

View Article and Find Full Text PDF
July 2017

New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints.

Clin Cancer Res 2016 Sep 1;22(17):4283-90. Epub 2016 Jul 1.

Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.

View Article and Find Full Text PDF
September 2016

B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Proc Natl Acad Sci U S A 2004 Feb 4;101(7):2005-10. Epub 2004 Feb 4.

Department of Biology and Center for Cancer Research and McGovern Institute, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4307, USA.

View Article and Find Full Text PDF
February 2004

Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Proc Natl Acad Sci U S A 2004 Feb 26;101(6):1473-8. Epub 2004 Jan 26.

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4-131, 4 Center Drive, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF
February 2004

Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Mol Cell Biol 2004 Feb;24(3):1022-32

Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA.

View Article and Find Full Text PDF
February 2004